These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 39167895)

  • 1. Discovery of potent HIV-1 NNRTIs by CuAAC click-chemistry-based miniaturized synthesis, rapid screening and structure optimization.
    Jing L; Wu G; Zhao F; Jiang X; Liu N; Feng D; Sun Y; Zhang T; De Clercq E; Pannecouque C; Kang D; Liu X; Zhan P
    Eur J Med Chem; 2024 Nov; 277():116772. PubMed ID: 39167895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ click chemistry-based rapid discovery of novel HIV-1 NNRTIs by exploiting the hydrophobic channel and tolerant regions of NNIBP.
    Kang D; Feng D; Jing L; Sun Y; Wei F; Jiang X; Wu G; De Clercq E; Pannecouque C; Zhan P; Liu X
    Eur J Med Chem; 2020 May; 193():112237. PubMed ID: 32200201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.
    Zhao T; Meng Q; Kang D; Ji J; De Clercq E; Pannecouque C; Liu X; Zhan P
    Eur J Med Chem; 2019 Nov; 182():111619. PubMed ID: 31434039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.
    Jin K; Yin H; De Clercq E; Pannecouque C; Meng G; Chen F
    Eur J Med Chem; 2018 Feb; 145():726-734. PubMed ID: 29353724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".
    Zhou Z; Liu T; Kang D; Huo Z; Wu G; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2018 Feb; 16(6):1014-1028. PubMed ID: 29349445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioisosterism-based design and enantiomeric profiling of chiral hydroxyl-substituted biphenyl-diarylpyrimidine nonnucleoside HIV-1 reverse transcriptase inhibitors.
    Chen X; Ding L; Tao Y; Pannecouque C; De Clercq E; Zhuang C; Chen FE
    Eur J Med Chem; 2020 Sep; 202():112549. PubMed ID: 32712537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-guided design of novel biphenyl-quinazoline derivatives as potent non-nucleoside reverse transcriptase inhibitors featuring improved anti-resistance, selectivity, and solubility.
    Wang JS; Zhao KX; Zhang K; Pannecouque C; De Clercq E; Wang S; Chen FE
    Bioorg Chem; 2024 Jun; 147():107340. PubMed ID: 38593532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors.
    Feng D; Lin H; Jiang L; Wang Z; Sun Y; Zhou Z; Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of 2,4,6-trisubstituted pyrimidine derivatives as novel potent HIV-1 NNRTIs by exploiting the tolerant region II of the NNIBP.
    Zhou Z; Sun Y; Qin Y; Wang N; Zhao F; Wang Z; Clercq E; Pannecouque C; Zhan P; Kang D; Liu X
    Eur J Med Chem; 2024 Nov; 277():116708. PubMed ID: 39094273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In situ click chemistry-based discovery of 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs by exploiting the tolerant region I in binding pocket.
    Sun Y; Feng D; Zhou Z; Zhang T; De Clercq E; Pannecouque C; Kang D; Zhan P; Liu X
    Bioorg Med Chem; 2023 Dec; 96():117484. PubMed ID: 37976805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, Synthesis, and Evaluation of Thiophene[3,2-d]pyrimidine Derivatives as HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors with Significantly Improved Drug Resistance Profiles.
    Kang D; Fang Z; Li Z; Huang B; Zhang H; Lu X; Xu H; Zhou Z; Ding X; Daelemans D; De Clercq E; Pannecouque C; Zhan P; Liu X
    J Med Chem; 2016 Sep; 59(17):7991-8007. PubMed ID: 27541578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.
    Meng Q; Chen X; Kang D; Huang B; Li W; Zhan P; Daelemans D; De Clercq E; Pannecouque C; Liu X
    Eur J Med Chem; 2016 Jun; 115():53-62. PubMed ID: 26994843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.
    Zhou Z; Liu T; Wu G; Kang D; Fu Z; Wang Z; De Clercq E; Pannecouque C; Zhan P; Liu X
    Org Biomol Chem; 2019 Mar; 17(12):3202-3217. PubMed ID: 30839042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel potent HIV-1 inhibitors by exploiting the tolerant regions of the NNRTIs binding pocket.
    Sun Y; Kang D; Da F; Zhang T; Li P; Zhang B; De Clercq E; Pannecouque C; Zhan P; Liu X
    Eur J Med Chem; 2021 Mar; 214():113204. PubMed ID: 33567378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Indolylarylsulfones bearing phenylboronic acid and phenylboronate ester functionalities as potent HIV‑1 non-nucleoside reverse transcriptase inhibitors.
    Xu S; Song S; Sun L; Gao P; Gao S; Ma Y; Kang D; Cheng Y; Zhang X; Cherukupalli S; De Clercq E; Pannecouque C; Liu X; Zhan P
    Bioorg Med Chem; 2022 Jan; 53():116531. PubMed ID: 34890994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Triazinone Derivative Inhibits HIV-1 Replication by Interfering with Reverse Transcriptase Activity.
    Urano E; Miyauchi K; Kojima Y; Hamatake M; Ablan SD; Fudo S; Freed EO; Hoshino T; Komano J
    ChemMedChem; 2016 Oct; 11(20):2320-2326. PubMed ID: 27634404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of Novel Amino Acids (Analogues)-Substituted Thiophene[3,2-
    Zhuo Z; Wang Z; Jing L; Zhang T; Ge A; Zhou Z; Liu Y; Li X; De Clercq E; Pannecouque C; Zhan P; Liu X; Kang D
    Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Dihydrofuro[3,4- d]pyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors with Promising Antiviral Activities and Desirable Physicochemical Properties.
    Kang D; Zhang H; Wang Z; Zhao T; Ginex T; Luque FJ; Yang Y; Wu G; Feng D; Wei F; Zhang J; De Clercq E; Pannecouque C; Chen CH; Lee KH; Murugan NA; Steitz TA; Zhan P; Liu X
    J Med Chem; 2019 Feb; 62(3):1484-1501. PubMed ID: 30624934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.
    Yang J; Chen W; Kang D; Lu X; Li X; Liu Z; Huang B; Daelemans D; Pannecouque C; De Clercq E; Zhan P; Liu X
    Eur J Med Chem; 2016 Feb; 109():294-304. PubMed ID: 26802545
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.